Great Novel Therapeutics Biotech & Medicals (TPEX:7427)
Taiwan
· Delayed Price · Currency is TWD 40.10
-0.80 (-1.96%)
Apr 29, 2026, 1:58 PM CST
TPEX:7427 Balance Sheet
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | 29.84 | 155.06 | 179.55 | 111.08 | 62.79 | Upgrade
|
| Short-Term Investments | 417.7 | 427.7 | 297 | 136.5 | 62.32 | Upgrade
|
| Cash & Short-Term Investments | 447.54 | 582.76 | 476.55 | 247.58 | 125.1 | Upgrade
|
| Cash Growth | -23.20% | 22.29% | 92.48% | 97.90% | 86.65% | Upgrade
|
| Accounts Receivable | 0.06 | 0.72 | 0.09 | - | - | Upgrade
|
| Other Receivables | 0.75 | 0.67 | 0.47 | 0.1 | 0.07 | Upgrade
|
| Receivables | 0.81 | 1.39 | 0.56 | 0.1 | 0.07 | Upgrade
|
| Inventory | 7.3 | 3.01 | 6.16 | - | - | Upgrade
|
| Prepaid Expenses | 10.57 | 1.99 | 0.38 | 0.76 | 0.01 | Upgrade
|
| Other Current Assets | 0.24 | 9.55 | 1.8 | 3.01 | 0.22 | Upgrade
|
| Total Current Assets | 466.45 | 598.7 | 485.45 | 251.45 | 125.41 | Upgrade
|
| Property, Plant & Equipment | 9.88 | 13.63 | 16.01 | 0.12 | 0.12 | Upgrade
|
| Other Intangible Assets | 27.1 | 27.53 | 29.16 | 15.27 | 88.6 | Upgrade
|
| Long-Term Deferred Charges | - | 1.21 | 6.96 | 5.94 | 3.5 | Upgrade
|
| Other Long-Term Assets | 23.33 | 21.52 | 23.67 | 15.92 | 12.34 | Upgrade
|
| Total Assets | 526.75 | 662.6 | 561.25 | 288.71 | 229.96 | Upgrade
|
| Accounts Payable | 0.4 | 0.11 | 0.62 | 0.83 | 0.86 | Upgrade
|
| Accrued Expenses | - | 17.6 | 10.05 | 10.63 | 20.42 | Upgrade
|
| Current Portion of Leases | 3.02 | 2.9 | 2.87 | - | - | Upgrade
|
| Other Current Liabilities | 15.92 | 1.22 | 2.39 | 0.59 | 0.33 | Upgrade
|
| Total Current Liabilities | 19.34 | 21.82 | 15.93 | 12.05 | 21.61 | Upgrade
|
| Long-Term Leases | 4.43 | 7.45 | 10.88 | - | - | Upgrade
|
| Total Liabilities | 23.77 | 29.28 | 26.81 | 12.05 | 21.61 | Upgrade
|
| Common Stock | 437.06 | 436.44 | 383.58 | 292.87 | 225.75 | Upgrade
|
| Additional Paid-In Capital | 753.54 | 742.07 | 591.12 | 363.05 | 221.94 | Upgrade
|
| Retained Earnings | -642.65 | -545.18 | -440.26 | -379.26 | -239.34 | Upgrade
|
| Treasury Stock | -44.97 | - | - | - | - | Upgrade
|
| Shareholders' Equity | 502.98 | 633.32 | 534.44 | 276.66 | 208.36 | Upgrade
|
| Total Liabilities & Equity | 526.75 | 662.6 | 561.25 | 288.71 | 229.96 | Upgrade
|
| Total Debt | 7.45 | 10.36 | 13.75 | - | - | Upgrade
|
| Net Cash (Debt) | 440.09 | 572.4 | 462.8 | 247.58 | 125.1 | Upgrade
|
| Net Cash Growth | -23.12% | 23.68% | 86.93% | 97.90% | 86.65% | Upgrade
|
| Net Cash Per Share | 10.20 | 13.89 | 12.76 | 10.25 | 5.93 | Upgrade
|
| Filing Date Shares Outstanding | 43.03 | 43.64 | 38.36 | 29.29 | 22.57 | Upgrade
|
| Total Common Shares Outstanding | 43.03 | 43.64 | 38.36 | 29.29 | 22.57 | Upgrade
|
| Working Capital | 447.11 | 576.87 | 469.52 | 239.41 | 103.8 | Upgrade
|
| Book Value Per Share | 11.69 | 14.51 | 13.93 | 9.45 | 9.23 | Upgrade
|
| Tangible Book Value | 475.89 | 605.79 | 505.28 | 261.39 | 119.75 | Upgrade
|
| Tangible Book Value Per Share | 11.06 | 13.88 | 13.17 | 8.93 | 5.30 | Upgrade
|
| Machinery | - | 7.63 | 5.69 | 3.2 | 3.21 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.